{"id":45761,"date":"2021-11-12T06:23:01","date_gmt":"2021-11-12T11:23:01","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=45761"},"modified":"2021-11-12T00:25:07","modified_gmt":"2021-11-12T05:25:07","slug":"pfizer-inc-nyse-pfe-gets-approval-for-childrens-covid-19-vaccine","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nyse-pfe-gets-approval-for-childrens-covid-19-vaccine-45761","title":{"rendered":"Pfizer Inc (NYSE: PFE) Gets Approval For Children’s COVID-19 Vaccine"},"content":{"rendered":"

Pfizer Inc (NYSE: PFE)<\/strong> has announced that the U.S Food and Drug Administration (FDA) has approved its COVID-19 vaccine for children aged 5-11. The Centre for Disease Control and Prevention’s immunization advisory committee also met to decide how healthcare workers administer the shot and who will receive it. Rochelle Walensky, the director, signed off on the recommendations. The vaccine, a third of the adult dose, will be available for free in schools, temporary clinics, and 100 children\u2019s hospitals.<\/p>\n

In addition, the CEO of Pfizer, Albert Bourla, has made comments on the current prescription drug prices in the U.S. The drug prices in the U.S are three times higher than in other countries. Bourla acknowledges this, saying government officials should do something about it. However, he points out that there has been a 5% decrease in drug prices in the last year. Despite this, drug prices do not seem to benefit patients. Bourla adds that the problem is with the healthcare system as a whole.<\/p>\n

Moderna Inc (NASDAQ: MRNA) says it has the long-term advantage over Pfizer<\/b><\/p>\n

Although Moderna Inc (NASDAQ: MRNA) has been lagging behind Pfizer regarding COVID-19 vaccine production, the company says it has the long-term advantage. The president of Moderna, Stephane Hoge, states that Pfizer had experience in mass production and fast clinical trials, something that Moderna did not. However, unlike Moderna, Pfizer does not use mRNA technology; hence their vaccine will be harder to combine with other mRNA vaccines.<\/p>\n

Navajo Nation reports spike in COVID-19 infection<\/b><\/p>\n

The Navajo Nation, the most significant U.S reservation, has reported another surge in COVID-19 infection despite being one of the most highly vaccinated regions in the country, with about 70% of the population having received vaccines. Only about 58% of the general U.S population has gotten vaccines.<\/p>\n

According to the Indian Health Service, the reservation is getting infected by neighboring states with low vaccination rates as many of the tribal members commute to work in these areas. Fortunately, the cases of infection are not severe as most eligible members are vaccinated. Other reservations, such as the Blackfeet Nation, have experienced a spike despite most of their populations receiving vaccines.<\/p>\n","protected":false},"excerpt":{"rendered":"

Pfizer Inc (NYSE: PFE) has announced that the U.S Food and Drug Administration (FDA) has approved its COVID-19 vaccine for children aged 5-11. The Centre […]<\/p>\n","protected":false},"author":13,"featured_media":41971,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264],"tags":[993,207,15819,15820,15501],"stock_ticker":[13841],"class_list":["post-45761","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-nysepfe","tag-pfe","tag-pfe-news","tag-pfe-stock","tag-pfizer-inc-nyse-pfe","stock_ticker-pfe","entry"],"acf":[],"yoast_head":"\nPfizer Inc (NYSE: PFE) Gets Approval For Children's COVID-19 Vaccine - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nyse-pfe-gets-approval-for-childrens-covid-19-vaccine-45761\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pfizer Inc (NYSE: PFE) Gets Approval For Children's COVID-19 Vaccine - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Pfizer Inc (NYSE: PFE) has announced that the U.S Food and Drug Administration (FDA) has approved its COVID-19 vaccine for children aged 5-11. The Centre […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nyse-pfe-gets-approval-for-childrens-covid-19-vaccine-45761\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2021-11-12T11:23:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/07\/Pfizer-Inc..jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"660\" \/>\n\t<meta property=\"og:image:height\" content=\"440\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Lisa Ray\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Lisa Ray\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nyse-pfe-gets-approval-for-childrens-covid-19-vaccine-45761#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nyse-pfe-gets-approval-for-childrens-covid-19-vaccine-45761\"},\"author\":{\"name\":\"Lisa Ray\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/c58aa72f5e3994c817e3654937496b1c\"},\"headline\":\"Pfizer Inc (NYSE: PFE) Gets Approval For Children’s COVID-19 Vaccine\",\"datePublished\":\"2021-11-12T11:23:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nyse-pfe-gets-approval-for-childrens-covid-19-vaccine-45761\"},\"wordCount\":370,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nyse-pfe-gets-approval-for-childrens-covid-19-vaccine-45761#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/07\/Pfizer-Inc..jpg\",\"keywords\":[\"NYSE:PFE\",\"PFE\",\"PFE News\",\"PFE Stock\",\"Pfizer Inc. (NYSE: PFE)\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nyse-pfe-gets-approval-for-childrens-covid-19-vaccine-45761\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nyse-pfe-gets-approval-for-childrens-covid-19-vaccine-45761\",\"name\":\"Pfizer Inc (NYSE: PFE) Gets Approval For Children's COVID-19 Vaccine - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nyse-pfe-gets-approval-for-childrens-covid-19-vaccine-45761#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nyse-pfe-gets-approval-for-childrens-covid-19-vaccine-45761#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/07\/Pfizer-Inc..jpg\",\"datePublished\":\"2021-11-12T11:23:01+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nyse-pfe-gets-approval-for-childrens-covid-19-vaccine-45761#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nyse-pfe-gets-approval-for-childrens-covid-19-vaccine-45761\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nyse-pfe-gets-approval-for-childrens-covid-19-vaccine-45761#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/07\/Pfizer-Inc..jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/07\/Pfizer-Inc..jpg\",\"width\":660,\"height\":440},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nyse-pfe-gets-approval-for-childrens-covid-19-vaccine-45761#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pfizer Inc (NYSE: PFE) Gets Approval For Children’s COVID-19 Vaccine\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/c58aa72f5e3994c817e3654937496b1c\",\"name\":\"Lisa Ray\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/2b2b9819092dcc9a125cbbf7b3645b09.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/2b2b9819092dcc9a125cbbf7b3645b09.png\",\"caption\":\"Lisa Ray\"},\"description\":\"Lisa has a Bachelor of Arts in journalism from Purdue University and 3 years of experience in the publishing field.\",\"sameAs\":[\"https:\/\/cablemanpro.com\/wallstreetpr\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/linsay-thomas\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pfizer Inc (NYSE: PFE) Gets Approval For Children's COVID-19 Vaccine - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nyse-pfe-gets-approval-for-childrens-covid-19-vaccine-45761","og_locale":"en_US","og_type":"article","og_title":"Pfizer Inc (NYSE: PFE) Gets Approval For Children's COVID-19 Vaccine - Wall Street PR","og_description":"Pfizer Inc (NYSE: PFE) has announced that the U.S Food and Drug Administration (FDA) has approved its COVID-19 vaccine for children aged 5-11. The Centre […]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nyse-pfe-gets-approval-for-childrens-covid-19-vaccine-45761","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2021-11-12T11:23:01+00:00","og_image":[{"width":660,"height":440,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/07\/Pfizer-Inc..jpg","type":"image\/jpeg"}],"author":"Lisa Ray","twitter_misc":{"Written by":"Lisa Ray","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nyse-pfe-gets-approval-for-childrens-covid-19-vaccine-45761#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nyse-pfe-gets-approval-for-childrens-covid-19-vaccine-45761"},"author":{"name":"Lisa Ray","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/c58aa72f5e3994c817e3654937496b1c"},"headline":"Pfizer Inc (NYSE: PFE) Gets Approval For Children’s COVID-19 Vaccine","datePublished":"2021-11-12T11:23:01+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nyse-pfe-gets-approval-for-childrens-covid-19-vaccine-45761"},"wordCount":370,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nyse-pfe-gets-approval-for-childrens-covid-19-vaccine-45761#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/07\/Pfizer-Inc..jpg","keywords":["NYSE:PFE","PFE","PFE News","PFE Stock","Pfizer Inc. (NYSE: PFE)"],"articleSection":["Health"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nyse-pfe-gets-approval-for-childrens-covid-19-vaccine-45761","url":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nyse-pfe-gets-approval-for-childrens-covid-19-vaccine-45761","name":"Pfizer Inc (NYSE: PFE) Gets Approval For Children's COVID-19 Vaccine - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nyse-pfe-gets-approval-for-childrens-covid-19-vaccine-45761#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nyse-pfe-gets-approval-for-childrens-covid-19-vaccine-45761#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/07\/Pfizer-Inc..jpg","datePublished":"2021-11-12T11:23:01+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nyse-pfe-gets-approval-for-childrens-covid-19-vaccine-45761#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nyse-pfe-gets-approval-for-childrens-covid-19-vaccine-45761"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nyse-pfe-gets-approval-for-childrens-covid-19-vaccine-45761#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/07\/Pfizer-Inc..jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/07\/Pfizer-Inc..jpg","width":660,"height":440},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/pfizer-inc-nyse-pfe-gets-approval-for-childrens-covid-19-vaccine-45761#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Pfizer Inc (NYSE: PFE) Gets Approval For Children’s COVID-19 Vaccine"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/c58aa72f5e3994c817e3654937496b1c","name":"Lisa Ray","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/2b2b9819092dcc9a125cbbf7b3645b09.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/2b2b9819092dcc9a125cbbf7b3645b09.png","caption":"Lisa Ray"},"description":"Lisa has a Bachelor of Arts in journalism from Purdue University and 3 years of experience in the publishing field.","sameAs":["https:\/\/cablemanpro.com\/wallstreetpr"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/linsay-thomas"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/45761","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=45761"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/45761\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/41971"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=45761"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=45761"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=45761"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=45761"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}